Last reviewed · How we verify

NCT04204018

Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia

Completed NA Last updated 10 February 2020
What this trial tests

NA trial testing Experimental Arm in Pre-Eclampsia in 108 participants. Completed in 23 December 2019.

Timeline
22 November 2019
Primary endpoint
23 December 2019
23 December 2019

Quick facts

Lead sponsorQure Healthcare, LLC
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment108
Start date22 November 2019
Primary completion23 December 2019
Estimated completion23 December 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Qure Healthcare, LLC — full company profile →

Who can join

Eligibility, any sex, with Pre-Eclampsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will collect high-quality data on how practicing obstetricians across the U.S. currently manage patients showing signs and/or symptoms of preeclampsia and how the results of Progenity's test change clinical decision making. To do so, this study leverages simulated patient cases called Clinical Performance and Value vignettes (CPVs) in a proven methodology to rapidly measure physician care decisions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Experimental Arm

Trials testing the same drug.

Other recruiting trials for Pre-Eclampsia

Currently open trials in the same condition.

Other Qure Healthcare, LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04204018.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing